Androgenic alopecia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Signed an informed consent form and agreed to participate in this study; 2. Chinese men or women aged 18 years or above; 3. Diagnosis of androgenic alopecia, MPHL and FPHL graded as Norwood– Hamilton grades II–VI or Ludwig Class I–III;
Exclusion criteria
Exclusion criteria: 1. Severe hematological diseases; 2. Severe hepatic and renal dysfunction, blood glucose and dyslipidemia; 3. Infectious diseases (hepatitis A, hepatitis B, AIDS, syphilis, etc.); 4. Immune systemic disease; 5. 1 month before entering the study,those who had received systemic use of corticosteroids, immunosuppressants, non-steroidal anti-inflammatory drugs, anti-allergic drugs and contraceptives etc; 6. Six months before entering the study, minoxidil and other hair growth promoting drugs were topically used, or oral finasteride was taken; 7. Women who are menstruating and pregnant and who are breastfeeding,Or women of childbearing age who do not receive adequate contraception or who plan to become pregnant during the study; 8. Known or previously allergic to any local anesthetic, such as lidocaine or other amide anesthetics; 9. History of radiotherapy at the site to be treated, or cancerous or precancerous lesions; 10. Scars or deformities, active dermatosis, inflammation or related diseases on or near the site to be treated; 11. The researchers believe that any medical symptoms that make the subjects unsuitable for selection (such as chronic, recurrent or genetic diseases that may affect the general condition or require frequent treatment, any abnormal laboratory or ECG results or mental illness during screening); 12. Other researchers believe that it is not suitable for the subjects to be selected, such as the subjects are unreliable, unable to accept or understand the evaluation of the study, or unrealistic expectations of the treatment outcome; 13. Have a history of severe or multiple allergies; 14. Disagree with this research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair growth photo;Hair density and diameter;Quantitative analysis of hair growth in the same part; | — |
Secondary
| Measure | Time frame |
|---|---|
| 7 Comment subscale to analyze the improvement of subjects’ hair;Subjective satisfaction evaluation of volunteers; | — |
Countries
China
Contacts
Department of Plastic Surgery, Affiliated Hospital of Zunyi Medical University